0000899243-23-012178.txt : 20230503 0000899243-23-012178.hdr.sgml : 20230503 20230503211611 ACCESSION NUMBER: 0000899243-23-012178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WELCH DANIEL G CENTRAL INDEX KEY: 0001206199 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 23886082 MAIL ADDRESS: STREET 1: 4611 UNIVERSITY DR STREET 2: 4 UNIVERSITY PLACE CITY: DURHAM STATE: NC ZIP: 27707 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-01 0 0001060736 Seagen Inc. SGEN 0001206199 WELCH DANIEL G 21823 30TH DRIVE SE BOTHELL WA 98021 1 0 0 0 1 Common Stock 2023-05-01 4 M 0 5150 64.38 A 12049 D Common Stock 2023-05-01 4 S 0 5150 200.04 D 6899 D Common Stock 2023-05-01 4 M 0 1990 56.77 A 8889 D Common Stock 2023-05-01 4 S 0 1990 200.12 D 6899 D Common Stock 2023-05-01 4 S 0 295 200.06 D 6604 D Common Stock 2023-05-01 4 S 0 4890 200.06 D 18170 I by Trust Common Stock 2023-05-02 4 M 0 1888 64.38 A 8492 D Common Stock 2023-05-02 4 S 0 1888 200.05 D 6604 D Common Stock 2023-05-02 4 M 0 3171 160.33 A 9775 D Common Stock 2023-05-02 4 S 0 3171 200.05 D 6604 D Common Stock 2023-05-02 4 M 0 3462 147.50 A 10066 D Common Stock 2023-05-02 4 S 0 3462 200.10 D 6604 D Common Stock 2023-05-02 4 S 0 351 200.07 D 6253 D Common Stock 2023-05-02 4 S 0 5835 200.07 D 12335 I by Trust Non-Qualified Stock Option (right to buy) 56.77 2023-05-01 4 M 0 1990 0.00 D 2028-05-18 Common Stock 1990 0 D Non-Qualified Stock Option (right to buy) 64.38 2023-05-01 4 M 0 5150 0.00 D 2029-05-20 Common Stock 5150 1888 D Non-Qualified Stock Option (right to buy) 64.38 2023-05-02 4 M 0 1888 0.00 D 2029-05-20 Common Stock 1888 0 D Non-Qualified Stock Option (right to buy) 160.33 2023-05-02 4 M 0 3171 0.00 D 2030-05-15 Common Stock 3171 0 D Non-Qualified Stock Option (right to buy) 147.50 2023-05-02 4 M 0 3462 0.00 D 2031-05-14 Common Stock 3462 0 D Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. Sales reported in this Form 4 were effected pursuant to written plans, entered into on September 7, 2022, that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.06. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $200.03 to $200.41. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.41. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $200.02 to $200.43. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.05. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.08. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $200.05 to $200.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Reflects sales of common stock executed in multiple transactions at prices ranging from $200.04 to $200.16 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Options vested in full on 5/18/19. Options vested in full on 5/20/20. Options vested in full on 5/15/21. Options vested in full on 5/14/22. By: /s/ Jennifer Prosba For: Daniel G. Welch 2023-05-03